NEW YORK (GenomeWeb) – Agilent Technologies today announced that it will provide access to its bioanalytical instruments to National University of Singapore Yong Loo Lin School of Medicine (NUS Medicine) for use in a study of patient responses to cardiovascular medicines.

Under the terms of their arrangement, the school's department of medicine will have access to Agilent's proof-of-concept laboratory in Singapore, which includes its 6550 iFunnel quadrupole time-of-flight liquid chromatography mass spectrometry system, as well as its Capillary Electrophoresis System model 7100.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.